These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19093253)

  • 1. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
    Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
    Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
    Shen HW; Wu YL; Peng SY
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
    Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
    Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between expression of DcR3 on tumor cells and sensitivity to FasL.
    Li W; Zhang C; Chen C; Zhuang G
    Cell Mol Immunol; 2007 Dec; 4(6):455-60. PubMed ID: 18163957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cells.
    Sung HY; Wu HG; Ahn JH; Park WY
    Int J Radiat Biol; 2010 Sep; 86(9):780-90. PubMed ID: 20597837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid.
    Mueller AM; Pedré X; Killian S; David M; Steinbrecher A
    J Neuroimmunol; 2009 Apr; 209(1-2):57-64. PubMed ID: 19269042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma.
    Arakawa Y; Tachibana O; Hasegawa M; Miyamori T; Yamashita J; Hayashi Y
    Acta Neuropathol; 2005 Mar; 109(3):294-8. PubMed ID: 15627206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo?
    Nagao M; Nakajima Y; Hisanaga M; Kayagaki N; Kanehiro H; Aomatsu Y; Ko S; Yagita H; Yamada T; Okumura K; Nakano H
    Hepatology; 1999 Aug; 30(2):413-21. PubMed ID: 10421649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of decoy receptor 3 in liver tissue microarrays.
    Chen G; Luo D
    Natl Med J India; 2008; 21(6):275-8. PubMed ID: 19691215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma.
    Nagao M; Nakajima Y; Kanehiro H; Hisanaga M; Aomatsu Y; Ko S; Tatekawa Y; Ikeda N; Kanokogi H; Urizono Y; Kobayashi T; Shibaji T; Kanamura T; Ogawa S; Nakano H
    Hepatology; 2000 Sep; 32(3):491-500. PubMed ID: 10960440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
    Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
    Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DcR3 protects islet beta cells from apoptosis through modulating Adcyap1 and Bank1 expression.
    Han B; Wu J
    J Immunol; 2009 Dec; 183(12):8157-66. PubMed ID: 20007581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.
    Pitti RM; Marsters SA; Lawrence DA; Roy M; Kischkel FC; Dowd P; Huang A; Donahue CJ; Sherwood SW; Baldwin DT; Godowski PJ; Wood WI; Gurney AL; Hillan KJ; Cohen RL; Goddard AD; Botstein D; Ashkenazi A
    Nature; 1998 Dec; 396(6712):699-703. PubMed ID: 9872321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of FasL expression in tumor cells and preventing tumor necrosis factor-induced apoptosis by adenovirus 14.7K is an effective escape mechanism for immune cells.
    Zhang J; Xu G
    Cancer Genet Cytogenet; 2007 Dec; 179(2):112-7. PubMed ID: 18036397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the Fas/FasL system improves pneumococcal clearance from the lungs without preventing dissemination of bacteria to the spleen.
    Matute-Bello G; Liles WC; Frevert CW; Dhanireddy S; Ballman K; Wong V; Green RR; Song HY; Witcher DR; Jakubowski JA; Martin TR
    J Infect Dis; 2005 Feb; 191(4):596-606. PubMed ID: 15655784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus.
    Han B; Bojalil R; Amezcua-Guerra LM; Springall R; Valderrama-Carvajal H; Wu J; Luo H
    Int Immunol; 2008 Aug; 20(8):1067-75. PubMed ID: 18562337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
    Chang PM; Chen PM; Hsieh SL; Tzeng CH; Liu JH; Chiou TJ; Wang WS; Yen CC; Gau JP; Yang MH
    Int J Oncol; 2008 Sep; 33(3):549-54. PubMed ID: 18695885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome.
    Han B; Moore PA; Wu J; Luo H
    Arthritis Rheum; 2007 Nov; 56(11):3748-58. PubMed ID: 17968950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH; Chen CL; Li WY; Chen CJ
    Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.